David Michael Steinhaus MD
Adult Congenital Heart Disease, Cardiac Electrophysiology
Vice President Medtronic
Join to View Full Profile
200 Park AveMinneapolis, MN 55415
Phone+1 763-514-3577
Dr. Steinhaus is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General HospitalFellowship, Clinical Cardiac Electrophysiology, 1983 - 1984- Mass General Brigham/Massachusetts General HospitalFellowship, Cardiovascular Disease, 1980 - 1983
- Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1977 - 1980
Harvard Medical SchoolClass of 1977
Certifications & Licensure
MN State Medical License 2006 - 2026
MO State Medical License 1984 - 2026
KS State Medical License 1996 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- AdaptResponse Clinical Trial Start of enrollment: 2014 Aug 01
Publications & Presentations
PubMed
- 11 citationsCurrent state of knowledge and experts' perspective on the subcutaneous implantable cardioverter-defibrillator.Massimo Santini, Riccardo Cappato, Dietrich Andresen, Johannes Brachmann, D. Wyn Davies
Journal of Interventional Cardiac Electrophysiology. 2009-03-06 - Fifty Years of Pacemaker AdvancementsDavid Steinhaus
Journal of Cardiovascular Translational Research. 2008-11-04 - 13 citationsIncreased base rate of atrial pacing for prevention of atrial fibrillation after implantation of a dual-chamber pacemaker: Insights from the atrial overdrive pacing studyBharat K. Kantharia, Roger A. Freedman, David Hoekenga, Gery Tomassoni, Seth J. Worley
Europace. 2007-11-01
Press Mentions
Medtronic’s Implantable System for Remodulin to Treat Patients with Pulmonary Arterial Hypertension Gets FDA ApprovalAugust 9th, 2018
FDA Approves Medtronic’s Implantable System for Remodulin to Treat PAHAugust 1st, 2018
Medtronic, United Receive Approval for Fully Implantable PAH Infusion PumpAugust 1st, 2018- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
